Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial

To assess the efficacy of ivermectin in addition to standard treatment compared to standard treatment alone in reducing hospitalizations in the COVID-19 patient population. IVERCOR-COVID19 will be a single-center, prospective, randomized, double-blind, parallel group (1:1 ratio), placebo-controlled...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current controlled trials in cardiovascular medicine 2020-11, Vol.21 (1), p.965-965, Article 965
Hauptverfasser:	Vallejos, Julio, Zoni, Rodrigo, Bangher, Maria, Villamandos, Silvina, Bobadilla, Angelina, Plano, Fabian, Campias, Claudia, Chaparro Campias, Evangelina, Achinelli, Fernando, Guglielmone, Hector A, Ojeda, Jorge, Medina, Fernanda, Farizano Salazar, Diego, Andino, Gerardo, Ruiz Diaz, Natalia E, Kawerin, Pablo, Meza, Elba, Dellamea, Silvana, Aquino, Antonia, Flores, Victor, Martemucci, Carolina N, Vernengo, María Mercedes, Martinez, Silvina María, Segovia, Juan Emanuel, Aguirre, María Gabriela
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiparasitic Agents - administration & dosage Antiparasitic Agents - therapeutic use Argentina - epidemiology Birth control Breastfeeding & lactation Case-Control Studies Coronaviruses COVID-19 COVID-19 - drug therapy COVID-19 - epidemiology COVID-19 - virology Double-Blind Method Drug dosages Female Hemodialysis Hospitalization Hospitalization - statistics & numerical data Humans Infectious diseases Informed consent Ivermectin - administration & dosage Ivermectin - therapeutic use Letter Liver cirrhosis Liver diseases Male Menstruation Pandemics - prevention & control Participation Patients Placebos - administration & dosage Polymerase chain reaction Prospective Studies Public health SARS-CoV-2 - genetics Time Factors Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!